https://www.selleckchem.com/pr....oducts/plerixafor-8h
CTCs were detected in 17/88 (19%) patients, while DTCs were detected in 20/58 (34%). Patients with high RS were not more likely to have CTCs (18%) compared to patients with low/intermediate RS (20%; p = 0.919). Similarly, high RS was not associated with DTC detection, with DTCs present in 40% of patients with high RS versus 33% with low/intermediate RS (p = 0.687). In the subgroup of patients ≤ 50years, no associations were found between high RS and CTCs (p = 0.383) or DTCs (p = 0.234). High Oncotype DX RS did not correl
Me gusta
Comentario
Compartir
